Non-nucleoside inhibitors of HIV-1 reverse transcriptase
- 1 August 1993
- journal article
- Published by Springer Nature in Perspectives in Drug Discovery and Design
- Vol. 1 (1) , 181-192
- https://doi.org/10.1007/bf02171661
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-oneJournal of Medicinal Chemistry, 1993
- Imidazo[2′-3′-:6,5]dipyrido[3,2-b:2′,3′-e]-1,4-diazepines: non-nucleoside HIV-1 reverse transcriptase inhibitors with greater enzyme affinity than nevirapineBioorganic & Medicinal Chemistry Letters, 1992
- Synthesis and anti-HIV activity of pyrrolo-[1,2-d]-(1,4)-benzodiazepin-6-onesBioorganic & Medicinal Chemistry Letters, 1992
- Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: mispair extension frequenciesBiochemistry, 1992
- Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinonesJournal of Medicinal Chemistry, 1992
- Synthesis and anti-HIV activity of 2-, 3-, and 4-substituted analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)Journal of Medicinal Chemistry, 1991
- Interactions with tRNALys induce important structural changes in human immunodeficiency virus reverse transcriptaseFEBS Letters, 1990
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAVScience, 1986